The Long and Winding Road: Uptake, Acceptability, and Potential Influencing Factors of COVID-19 Vaccination in Austria.

Isabel King, Petra Heidler, Roy Rillera Marzo
Author Information
  1. Isabel King: Department of Public Health, St. Elizabeth University of Health and Social Work, 81106 Bratislava, Slovakia. ORCID
  2. Petra Heidler: Department of International Business and Export Management, IMC University of Applied Sciences Krems, 3500 Krems an der Donau, Austria. ORCID
  3. Roy Rillera Marzo: Department of Community Medicine, Faculty of Medicine, Asia Metropolitan University, Johor Bahru 81750, Malaysia. ORCID

Abstract

Acceptance of the COVID-19 vaccine will play a crucial role in combating the current pandemic. Vaccine rollouts have started in most countries. To reach the desirable vaccine coverage and to enhance its uptake, it is imperative to assess vaccine hesitancy.
METHODS: To assess the current vaccine acceptability in Austria and its influencing factors, an online survey was created and comprised fifteen questions segmented into a sociodemographic part and the acceptance and influencing factors of the approval of the COVID-19 vaccine.
RESULTS: In total, 70% of the 1350 respondents thought that the COVID-19 vaccine is an effective way to prevent and control the virus, while 13% disagreed and 17% were uncertain. Further, 71% approved the rapid development and rollout of the vaccine, while 55% were willing to accept the vaccine as soon as it became available, 18% did not want to get the vaccine, 17% wanted to delay, and 10% were already vaccinated.
CONCLUSIONS: The results show a generally positive attitude towards the new COVID-19 vaccine. The doctor's recommendation greatly influences the decision-making process, and tailored vaccine information can support a higher vaccine coverage.

Keywords

References

  1. Int J Public Health. 2020 Jul;65(6):711-712 [PMID: 32529534]
  2. EClinicalMedicine. 2020 Sep;26:100495 [PMID: 32838242]
  3. Vaccine. 2015 Aug 14;33(34):4180-90 [PMID: 25896377]
  4. Wien Klin Wochenschr. 2021 Jul;133(13-14):703-713 [PMID: 33313966]
  5. Vaccine. 2015 Aug 14;33(34):4161-4 [PMID: 25896383]
  6. Infect Disord Drug Targets. 2013 Feb;13(1):25-33 [PMID: 23675924]
  7. Hum Vaccin Immunother. 2019;15(11):2527-2533 [PMID: 31050594]
  8. Hum Vaccin Immunother. 2013 Aug;9(8):1774-8 [PMID: 23733039]
  9. Aust Prescr. 2021 Feb;44(1):19-25 [PMID: 33664546]
  10. J Public Health (Oxf). 2021 May 05;: [PMID: 33948665]
  11. Hum Vaccin Immunother. 2018 May 4;14(5):1038-1041 [PMID: 29206079]
  12. Brain Behav Immun. 2021 May;94:41-50 [PMID: 33713824]
  13. Ann Intern Med. 2020 Dec 15;173(12):964-973 [PMID: 32886525]
  14. Nat Med. 2021 Feb;27(2):225-228 [PMID: 33082575]
  15. Hum Vaccin Immunother. 2018 Jul 3;14(7):1599-1609 [PMID: 29617183]
  16. Wien Klin Wochenschr. 2017 Jan;129(1-2):59-64 [PMID: 27565644]
  17. Int J Womens Dermatol. 2021 Mar;7(2):228-229 [PMID: 33195788]
  18. PLoS One. 2020 Sep 2;15(9):e0237755 [PMID: 32877412]
  19. PLoS One. 2021 Apr 16;16(4):e0250123 [PMID: 33861765]

Word Cloud

Created with Highcharts 10.0.0vaccineCOVID-19Austriacurrentcoverageassesshesitancyinfluencingfactorsacceptance17%AcceptancewillplaycrucialrolecombatingpandemicVaccinerolloutsstartedcountriesreachdesirableenhanceuptakeimperativeMETHODS:acceptabilityonlinesurveycreatedcomprisedfifteenquestionssegmentedsociodemographicpartapprovalRESULTS:total70%1350respondentsthoughteffectivewaypreventcontrolvirus13%disagreeduncertain71%approvedrapiddevelopmentrollout55%willingacceptsoonbecameavailable18%wantgetwanteddelay10%alreadyvaccinatedCONCLUSIONS:resultsshowgenerallypositiveattitudetowardsnewdoctor'srecommendationgreatlyinfluencesdecision-makingprocesstailoredinformationcansupporthigherLongWindingRoad:UptakeAcceptabilityPotentialInfluencingFactorsVaccinationpublichealth

Similar Articles

Cited By